Who Should NOT Take Viagra
According to
FDA-updated information released in December 1998, the following
people should not take Viagra:
- Men who are
currently using medications that contain nitrates, such as
nitroglycerin should not use Viagra because taken together they
can lower blood pressure too much.
- Viagra should not
be used by women or children.
Other FDA Warnings Include:
Viagra was not
studied in patients who have a history of the following conditions:
- heart attack,
stroke, or life-threatening irregular heart rhythm within the last
6 months
- very low and very
high blood pressure
- heart failure or
unstable chest pain
Because of the blood
pressure lowering effect of Viagra, your doctor will evaluate your
overall medical condition to determine if this, in combination with
sexual activity, could adversely affect your health.
Viagra may cause a
rare but serious condition of prolonged erection (priapism). It is
important to contact your health care provider immediately if your
erection lasts longer than 4 hours. Men for whom sexual activity is
inadvisable may not be good candidates for Viagra.
Source: US Food and Drug
Administration |
Viagra™
for Treatment of Erectile Dysfunction
What is
Viagra™
?
Viagra™ (sildenafil
citrate) is a medication made by Pfizer Pharmaceuticals, and is the first
approved non-surgical treatment for erectile dysfunction (ED) that does
not have to be either injected or inserted directly into the penis to
achieve and maintain an erection. It was approved by the US Food and Drug
Administration (FDA) for prescription sale at the end of March,
1998.
Development history of Viagra: Originally developed by
Pfizer as a drug to help men who were suffering from chest pain,
sildenafil citrate as a heart medication did not show promise and studies
were stopped in 1992.
However, based on
published information about some properties contained in sildenafil
citrate, Pfizer researchers began to look at it as a treatment for
erectile dysfunction. It was re-evaluated for its effect on the ability of
men with ED to engage in sexual activity, and the ability to achieve and
maintain erection sufficient for satisfactory sexual activity.
Eventually, 21 randomized,
placebo-controlled clinical trials involving more than 3700 patients, ages
19 to 87 years, were held worldwide. The participants had varying degrees
of impotence associated with the following:
- diabetes
- spinal cord injury
- history of prostate
surgery
- no identifiable organic
cause
Some patients also had
coexisting illnesses, including hypertension and coronary artery disease.
The clinical trials found
Viagra to be so effective, the FDA approved it only six months after
submission, and without consulting an advisory committee of outside
experts because there were no troubling questions and no significant side
effects.
What are the
general precautions for taking Viagra ? Healthcare professionals advise cautious optimism
when considering using Viagra. Although data from the clinical trials are
very promising, prospective patients must have realistic expectations. The
drug is not an aphrodisiac, and does not change libido or desire. Viagra
does not directly cause penile erection, but affects the response to
sexual stimulation.
The FDA recommends that
men follow these general precautions before taking Viagra:
- If you are taking
medicines that contain nitrates, such as nitroglycerin, you should not
use Viagra. The two taken together can lower blood pressure too much.
- Viagra should not be
used by women or children.
- Have a complete medical
history and physical examination to determine the cause of your erectile
dysfunction.
- Men with medical
conditions that may cause a sustained erection such as sickle cell
anemia, leukemia or multiple myeloma, or a man who has an abnormally
shaped penis may not be able to take Viagra.
- Tell your physician
about all the medications you are taking - including over-the-counter
ones - because there are medications known to interact with Viagra.
- Viagra's use in
combination with other ED treatments has not been studied, therefore,
its use in combination with other treatments is not recommended.
| Possible Risks: Between March and
November 1998, the FDA investigated more than 200 reported
cases that involved death or serious illness. Many cases were
eliminated because of unverifiable information. They concentrated on
130 deaths of men who had been prescribed the drug. Of these, "two
men died from homicide and drowning; three had strokes; and 77 had
cardiovascular events (41 with definite or suspected myocardial
infarction, 27 with cardiac arrest, 6 with cardiac symptoms, and 3
with coronary artery disease). Cause of death was unmentioned or
unknown for 48 cases."
The FDA acknowledged
that number of deaths is a small percentage of the 6 million
prescriptions written in that time period, and that "An accumulation
of adverse event reports does not necessarily indicate that the
adverse event was caused by the drug; rather, the event may be due
to an underlying disease or some other factor(s)."
However, the FDA
felt that label or enclosure information and warnings should be
stronger. In November 1998, Pfizer revised the information in
consultation with the FDA. The new labeling is intended to help make
sure that consumers and doctors are fully informed about the:
- benefits and
risks of using Viagra
- consideration
that must be given to the cardiovascular status of patients prior
to prescribing Viagra
As with all approved
medications, the FDA continues to monitor the safety of Viagra by
carefully reviewing reports of death and other serious adverse
events and will continue to evaluate the need for regulatory
action.
Source: US Food and Drug
Administration |
What are the
side effects of Viagra ?
In
the clinical trials, when Viagra was taken on an as-recommended and
as-needed basis, the following adverse events were
reported:
- headache - 16 percent
with Viagra; 4 percent with the placebo
- flushing - 10 percent
with Viagra; 1 percent with the placebo
- indigestion - 7 percent
with Viagra; 2 percent with the placebo
- nasal congestion - 3
percent with Viagra; 2 percent with the placebo
- urinary tract infection
- 3 percent with Viagra; 4 percent with the placebo
- mild and temporary
visual changes (blue/green color perception changes, light perception
changes, and blurred vision) and also increased sensitivity to light or
blurred vision. - 3 percent with Viagra; 0 percent with the placebo
- diarrhea - 3 percent
with Viagra; 1 percent with the placebo
- dizziness - 2 percent
with Viagra; 1 percent with the placebo
- rash - 2 percent with
Viagra; 1 percent with the placebo
Side effects that occurred
less than 2 percent included respiratory tract infection, back pain, flu
syndrome, and arthralgia.
How does
Viagra work ?
The erection of
the penis involves release of nitric oxide (NO), a chemical that is
normally released in response to sexual stimulation, in the corpus
cavernosum of the penis.
- Nitric oxide then
activates an enzyme called guanylate cyclase, which, in turn, results in
increased levels of cyclic guanosine monophosphate (cGMP).
- This produces smooth-muscle relaxation in the corpus cavernosum and allows the inflow of
blood.
[There are
three types of muscles: smooth, cardiac, and striated. Smooth muscles
are those that are involuntary in action and are found principally in
internal organs.]
- Viagra (sildenafil
citrate) has no direct relaxant effect on the human corpus cavernosum.
- Instead, sildenafil
enhances the effect of nitric oxide (NO) by inhibiting phosphodiesterase
type 5 (PDE5).
- PDE5 is responsible for
degradation of cGMP in the corpus cavernosum, which causes the penis to
become flaccid, or relaxed.
- When sexual stimulation
causes local release of NO, sildenafil inhibits PDE5, which, in turn,
causes increased levels of cGMP in the corpus cavernosum. This results
in continued smooth-muscle relaxation, allows for inflow of blood to the
corpus cavernosum, and erection of the penis.
- Sildenafil at has no
effect in the absence of sexual stimulation.
Viagra for men with heart
disease:
Viagra™
has received another approval for its use among men with severe coronary
artery disease. The approval,
the result of a study recently published in the New England Journal of
Medicine, opens the door for discussion among physicians and heart
patients wishing to take the medication.
With
millions of men in the United States experiencing erectile
dysfunction, and the overlap of risk factors often contributing to
heart disease, the researchers felt there was a need to determine if the
use of sildenafil was dangerous to heart patients. The risk factors for
both erectile dysfunction and heart disease include older age, high blood
pressure and cholesterol levels, and diabetes.
The study involved
14 men who ranged in age from 61 to 72 years of age. The men all suffered from severe
coronary artery disease with nearly half of the participants also
suffering from hypertension and diabetes
. (Please note the small sample size used
for this study.)
The
men all had heart conditions stable enough to discontinue nitrate
medication for at least 24 hours prior to the study. It is recommended that individuals
undergoing nitrate therapy, often prescribed to manage the symptoms of
angina pectoris or chest pain caused by coronary heart disease, should not
take
Viagra. The
combination of the two medications can increase the risk of hypotension, which is
potentially fatal .
The participants were given
Viagra and then carefully monitored.
Measurements of their arterial blood pressure, pulmonary capillary, and
pulmonary artery pressures were recorded, as well as their heart rate and
cardiac output
.
The
results found that there were no significant changes in coronary blood
flow, heart rate, or cardiac output. The researchers also found slight
reductions in systemic vascular resistance and pulmonary vascular
resistance.
The study's authors conclude that Viagra does
not negatively affect men diagnosed with severe coronary artery disease. In addition, the researchers were able
to find a positive reaction with the drug improving the men's coronary
blood flow reserve.
This
is not the first time the medication has received the green light for use
among heart patients. The American
Heart Association also supports Viagra use if the patient's heart condition is
stable and they are not undergoing treatment involving the use of
nitrates .
Always consult your physician for more
information.
Click
here to view the
Online Resources page of this web.
|